Saunders M, Sweetman L, Robinson B, Roth K, Cohn R, Gravel R A
J Clin Invest. 1979 Dec;64(6):1695-702. doi: 10.1172/JCI109632.
Fibroblast cultures from two individuals with biotin-responsive organicacidemia were found to have a pleiotropic deficiency of propionyl-CoA carboxylase, beta-methylcrotonyl-CoA carboxylase, and pyruvate carboxylase activities after growth in biotin limited culture medium, conditions which do not affect the carboxylase activities of normal cells. All three enzyme activities were restored to normal levels after transferring the mutant strains to biotin-rich medium. Both patients excreted abnormal levels of an array of metabolic intermediates, including beta-methylcrotonate, beta-hydroxyisovalerate, beta-hydroxypropionate, and lactate, which reflect metabolic blocks at all three carboxylase sites.14 mutants deficient in only propionyl-CoA carboxylase activity from patients with propionicacidemia and the two biotin-responsive strains were examined for complementation with seven previously mapped pcc mutants. No new pcc complementation groups were identified. Nine of the mutants were mapped to group pccA. The remaining 12 mutants mapped to pccBC or its B or C subgroups, confirming the complex nature of this group. The biotin-responsive mutants failed to complement each other but did complement mutants from all the pcc groups. Thus biotin-responsive organicacidemia is defined by a new complementation group, bio. The results obtained in this study suggest that the bio mutants have a defect of either biotin transport or a common holocarboxylase synthetase required for the biotin activation of all three mitochondrial carboxylases.
在生物素限制的培养基中生长后,发现来自两名生物素反应性有机酸血症患者的成纤维细胞培养物存在丙酰辅酶A羧化酶、β-甲基巴豆酰辅酶A羧化酶和丙酮酸羧化酶活性的多效性缺陷,而这些条件并不影响正常细胞的羧化酶活性。将突变菌株转移至富含生物素的培养基后,所有三种酶活性均恢复至正常水平。两名患者均排泄出一系列代谢中间产物的异常水平,包括β-甲基巴豆酸、β-羟基异戊酸、β-羟基丙酸和乳酸,这反映了所有三个羧化酶位点的代谢阻滞。对来自丙酸血症患者的仅缺乏丙酰辅酶A羧化酶活性的14个突变体和两个生物素反应性菌株进行了与七个先前定位的pcc突变体的互补性检测。未鉴定出新的pcc互补组。其中9个突变体被定位到pccA组。其余12个突变体被定位到pccBC或其B或C亚组,证实了该组的复杂性。生物素反应性突变体彼此之间不能互补,但能与所有pcc组的突变体互补。因此,生物素反应性有机酸血症由一个新的互补组bio定义。本研究获得的结果表明,bio突变体存在生物素转运缺陷或所有三种线粒体羧化酶的生物素活化所需的共同全羧化酶合成酶缺陷。